MSB 2.17% $1.13 mesoblast limited

Ann: AHA Late-Breaker - Rexlemestrocel Improves Cardiac Outcomes, page-391

  1. 20 Posts.
    lightbulb Created with Sketch. 5
    go mesoblast hype team!!

    20 years of very successful hype and it continues.

    preparation for next equity raising???

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.